Frontage buys rival contract research firm

by Michael McCoy
April 16, 2018 | APPEARED IN VOLUME 96, ISSUE 16


The contract research organization Frontage Laboratories has acquired rival Concord Biosciences for an undisclosed sum. Frontage’s 650 employees offer drug development services from 14 locations in the U.S. and China. Ohio-based Concord, formerly Ricerca Biosciences, will bolster Frontage’s preclinical, agrochemical, and toxicology services, says Frontage CEO Song Li. Concord has 65 employees. Olon acquired Ricerca’s chemical manufacturing division last year.


This article has been sent to the following recipient:

Leave A Comment

*Required to comment